Literature DB >> 23564181

Genetics and autoantibodies.

Carlo Perricone1, Nancy Agmon-Levin, Fulvia Ceccarelli, Guido Valesini, Juan-Manuel Anaya, Yehuda Shoenfeld.   

Abstract

Autoimmune diseases (ADs) are chronic conditions initiated by the loss of immunological tolerance to self-antigens. The pathogenic hypothesis comprises a complex interaction between genetic, environmental and hormonal factors that interact with an individual over time generating a dysregulation of the immune system leading to disease development. Several polymorphic genes contribute to the development of ADs. Furthermore, age and gender play a major role by influencing hormone levels that can represent the fulcrum unbalancing from susceptibility to protection. Evidences suggest that while all these steps occur, the susceptible individual develops autoantibodies over a long time lapse. Such autoantibody production is genetically determined and finally, their presence seems to determine the clinical presentation of ADs. The genetic predisposition to the developments of autoantibodies and toward the disease process may overlap. The unveiling of these mechanisms could allow not only to treat but also to prevent the development of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564181     DOI: 10.1007/s12026-013-8396-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  127 in total

Review 1.  'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.

Authors:  Yehuda Shoenfeld; Nancy Agmon-Levin
Journal:  J Autoimmun       Date:  2010-08-13       Impact factor: 7.094

Review 2.  Are autoimmune diseases predictable?

Authors:  Gabriel J Tobón; Jacques-Olivier Pers; Carlos A Cañas; Adriana Rojas-Villarraga; Pierre Youinou; Juan-Manuel Anaya
Journal:  Autoimmun Rev       Date:  2011-10-07       Impact factor: 9.754

3.  ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen?

Authors:  F Seibold
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 4.  Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.

Authors:  Amelia R Hofstetter; Lucy C Sullivan; Aron E Lukacher; Andrew G Brooks
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

Review 5.  The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

Authors:  Yehuda Shoenfeld; Miri Blank; Mahmoud Abu-Shakra; Howard Amital; Ori Barzilai; Yackov Berkun; Nicola Bizzaro; Boris Gilburd; Gisele Zandman-Goddard; Uriel Katz; Ilan Krause; Pnina Langevitz; Ian R Mackay; Hedi Orbach; Maya Ram; Yaniv Sherer; Elias Toubi; M Eric Gershwin
Journal:  Isr Med Assoc J       Date:  2008-01       Impact factor: 0.892

6.  The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity.

Authors:  Juan-Manuel Anaya; Rodrigo Corena; John Castiblanco; Adriana Rojas-Villarraga; Yehuda Shoenfeld
Journal:  Expert Rev Clin Immunol       Date:  2007-07       Impact factor: 4.473

7.  Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci.

Authors:  David Ellinghaus; Eva Ellinghaus; Rajan P Nair; Philip E Stuart; Tõnu Esko; Andres Metspalu; Sophie Debrus; John V Raelson; Trilokraj Tejasvi; Majid Belouchi; Sarah L West; Jonathan N Barker; Sulev Kõks; Külli Kingo; Tobias Balschun; Orazio Palmieri; Vito Annese; Christian Gieger; H Erich Wichmann; Michael Kabesch; Richard C Trembath; Christopher G Mathew; Gonçalo R Abecasis; Stephan Weidinger; Susanna Nikolaus; Stefan Schreiber; James T Elder; Michael Weichenthal; Michael Nothnagel; Andre Franke
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

8.  Prevalence of hepatitis C serum antibody in autoimmune diseases.

Authors:  Nancy Agmon-Levin; Maya Ram; Ori Barzilai; Bat Sheva Porat-Katz; Ronit Parikman; Carlo Selmi; M Eric Gershwin; Juan-Manuel Anaya; Pierre Youinou; Nicola Bizzaro; Angela Tincani; Athanasios G Tzioufas; Ricard Cervera; Ljudmila Stojanovich; Javier Martin; Miguel Angel Gonzalez-Gay; Gabriele Valentini; Miri Blank; Marielle SanMarco; Blaz Rozman; Stefano Bombardieri; Salvatore De Vita; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2009-04-08       Impact factor: 7.094

9.  Flow cytometric analyses of the lymphocyte subsets in peripheral blood of children with untreated active juvenile dermatomyositis.

Authors:  M R O'Gorman; V Corrochano; J Roleck; M Donovan; L M Pachman
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

10.  Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.

Authors:  Adriana Rojas-Villarraga; Francisco J Diaz; Enrique Calvo-Páramo; Juan C Salazar; Antonio Iglesias-Gamarra; Ruben D Mantilla; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2008-12-30       Impact factor: 7.094

View more
  10 in total

Review 1.  Functional autoantibodies in systemic sclerosis.

Authors:  Jeannine Günther; Judith Rademacher; Jakob M van Laar; Elise Siegert; Gabriela Riemekasten
Journal:  Semin Immunopathol       Date:  2015-08-21       Impact factor: 9.623

2.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

3.  The spectrum between antiphospholipid syndrome and systemic lupus erythematosus.

Authors:  Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2014-03       Impact factor: 2.980

Review 4.  Anti-cardiac troponin antibodies in clinical human disease: a systematic review.

Authors:  Eduardo M Vilela; Rita Bettencourt-Silva; J Torres da Costa; Ana Raquel Barbosa; Marisa P Silva; Madalena Teixeira; João Primo; Vasco Gama Ribeiro; José Pedro L Nunes
Journal:  Ann Transl Med       Date:  2017-08

5.  Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle.

Authors:  S Colafrancesco; N Agmon-Levin; C Perricone; Y Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

6.  Systemic lupus erythematosus 2014.

Authors:  Juan-Manuel Anaya; Yehuda Shoenfeld; Ricard Cervera
Journal:  Autoimmune Dis       Date:  2014-03-24

Review 7.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

Review 8.  Immunosenescence, aging, and systemic lupus erythematous.

Authors:  Gladis Montoya-Ortiz
Journal:  Autoimmune Dis       Date:  2013-10-24

Review 9.  Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype.

Authors:  Fulvia Ceccarelli; Carlo Perricone; Paola Borgiani; Cinzia Ciccacci; Sara Rufini; Enrica Cipriano; Cristiano Alessandri; Francesca Romana Spinelli; Antonio Sili Scavalli; Giuseppe Novelli; Guido Valesini; Fabrizio Conti
Journal:  J Immunol Res       Date:  2015-12-21       Impact factor: 4.818

10.  Treatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients.

Authors:  Andrea Schuette; Arash Moghaddam; Petra Seemann; Georg N Duda; Gerhard Schmidmaier; Lutz Schomburg
Journal:  BBA Clin       Date:  2016-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.